Pfizer Inc.
New York, NY 4 processed 13Fs on this site, 2025 Q3 to 2026 Q2
- $170M
- 17 holdings
- 2026 Q2
- −28.9% QoQ
- Top 5 78.9%
AUM over time
Book
| ORIC, Oric Pharmaceuticals | Hold | 5,376,344 | $8.18 | $44M | — | — | |
| ARVN, Arvinas | Hold | 3,457,815 | $11.86 | $41M | — | — | |
| CELC, Celcuity | Hold | 349,406 | $99.74 | $35M | — | — | |
| WVE, Wave Life Sciences | Hold | 1,875,000 | $17.00 | $32M | — | — | |
| ALLO, Allogene Therapeutics | Hold | 22,032,040 | $1.37 | $30M | — | — | |
| ZURA, Zura Bio | Hold | 2,970,022 | $5.24 | $16M | — | — | |
| PYXS, Pyxis Oncology | Hold | 7,032,770 | $1.15 | $8.1M | — | — | |
| CRBU, Caribou Biosciences | Hold | 4,690,431 | $1.59 | $7.5M | — | — | |
| CRDF, Cardiff Oncology | Hold | 2,411,575 | $2.81 | $6.8M | — | — | |
| BHVN, Biohaven | Hold | 505,645 | $11.29 | $5.7M | — | — | |
| Spero Therapeutics | Hold | 2,362,348 | $2.33 | $5.5M | — | — | |
| NXTC, Nextcure | Hold | 157,646 | $14.19 | $2.2M | — | — | |
| ZNTL, Zentalis Pharmaceuticals | Hold | 953,834 | $1.35 | $1.3M | — | — | |
| QTTB, Q32 Bio | Hold | 277,777 | $3.32 | $922K | — | — | |
| ANTX, An2 Therapeutics | Hold | 715,295 | $1.14 | $815K | — | — | |
| BOLT, Bolt Biotherapeutics | Hold | 31,305 | $5.47 | $171K | — | — | |
| DNA, Ginkgo Bioworks | Hold | 2,928 | $8.31 | $24K | — | — | |
| Senseonics | Reduce −95.0% | 2,171 | $5.52 | $12K | −41,255 | −$7K |
Exits / last held
Gone since 2025 Q3, shown at their last reported size.
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| BNTX, Biontech | Exit | 0 | $98.62 | $164M | −1,658,361 | −$164M | |
| Tourmaline Bio | Exit | 0 | $47.83 | $61M | −1,272,214 | −$61M | |
| Holding | Exit | 0 | $0.1910 | $320K | −1,675,000 | −$320K |
Filings history
4 periods, with AUM normalized
| Period | Holds | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 17 | $170M | −28.9% | 13F-HR | 8/13/2026 | 000007800326000102 |
| 2026 Q1 | 18 | $239M | +1.3% | 13F-HR | 5/12/2026 | 000007800326000064 |
| 2025 Q4 | 18 | $236M | −46.0% | 13F-HR | 2/12/2026 | 000007800326000013 |
| 2025 Q3 | 21 | $437M | — | 13F-HR | 11/13/2025 | 000007800325000161 |
About
Pfizer Inc.
4 processed 13Fs on this site, 2025 Q3 to 2026 Q2
Further reading
As an Amazon Associate, FollowTheFilings earns from qualifying purchases.
- The Essays of Warren Buffett, 8th Ed., Warren Buffett, Lawrence A. Cunningham View on Amazon
- One Up On Wall Street (Lynch), Peter Lynch View on Amazon